Androstenediol [androstendiol]
topical
2
- Terms
-
androst-5-en-3b,17b- diol
-
5-Androstene-3,17-diol
5-Androstene-3beta-17beta-Diol
Androst-5-ene-3 beta,17 beta-Diol
Androst-5-ene-3,17-diol
Bisexovister
delta 5-Androstene-3 beta,17 beta-Diol
Delta 5-Androstenediol
Hermaphrodiol
Persistent link
https://www.medvik.cz/link/D015114
Definition
An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group (17-HYDROXYSTEROID DEHYDROGENASES), is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-HYDROXYSTEROID DEHYDROGENASES).
- DUI
- D015114 MeSH Browser
- CUI
- M0023251
- CAS
- Androst-5-ene-3,17-diol, (3beta,17beta)-
- Previous indexing
- Androstenediols (1975)
- History note
- 2004 (1976); use 5-ANDROSTENE-3,17-DIOL 1991-1997, use ANDROSTENEDIOLS 1976-1990
- Public note
- 2004; see ANDROST-5-ENE-3 BETA,17 BETA-DIOL 1998-2003, see 5-ANDROSTENE-3,17-DIOL 1991-1997, see ANDROSTENEDIOLS 1976-1990
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives 1
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood 1
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
Metharmon F Chemical MeSH Browser